Vice President of Corporate Development and Strategic Investment, Independence Blue Cross
Obediah Sang has more than 10 years of experience in corporate development, investing, and market strategy. In his role as Vice President of Corporate Development and Strategic Investments, he provides strategic oversight for mergers, acquisitions, divestitures, and strategic investing. Sang also oversees Independence’s strategic innovation portfolio and leads the company’s pursuit of new and innovative ways to grow business and drive diversification.
Since joining Independence in 2020, Sang has played a key role on several strategic initiatives on behalf of the company, including: Independence’s expanded relationship with Penn Medicine centered on Penn Medicine’s purchase of a minority equity stake in Tandigm Health. Penn’s long-term commitment to work with Tandigm focuses on primary care and aims to improve patient outcomes and contain costs.Independence’s investment in Quartet Health to achieve speed to quality mental health care for all patients. The partnership builds on Independence’s whole-person health initiative.
Sang holds board observer roles across several of Independence’s strategic innovation portfolio companies.
Obadiah received a bachelors in finance from Metropolitan State University and his MBA from the University of Iowa, Tippie College of Business.